Table 1.
Baseline data of participants and association with knowledge of clinical trials.
| Variables | No. of respondents (%) (N = 1,576) | Attitude toward participating in a clinical trial | Rho (P-value) | P-value* | |
|---|---|---|---|---|---|
| Positive (n = 909) | Negative (n = 667) | ||||
| Country | |||||
| Egypt | 448 (28.4) | 256 (28.2) | 192 (28.8) | 0.11 (<0.001) ** | 0.001 |
| KSA | 843 (53.5) | 516 (56.8) | 327 (49.0) | ||
| Jordan | 285 (18.1) | 137 (15.1) | 148 (22.2) | ||
| Gender | |||||
| Male | 907 (58) | 568 (63) | 339 (51.1) | 0.16 (<0.001) | 0.001 |
| Female | 658 (42) | 334 (37) | 324 (48.9) | ||
| Age categories | |||||
| 18–29 | 403 (25.6) | 245 (27.0) | 158 (23.7) | −0.07 (0.004) | 0.46 |
| 30–39 | 611 (38.8) | 351 (38.6) | 260 (39.0) | ||
| 40–49 | 353 (22.4) | 190 (20.9) | 163 (24.4) | ||
| 50–59 | 155 (9.8) | 92 (10.1) | 63 (9.4) | ||
| 60–69 | 45 (2.9) | 27 (3.0) | 18 (2.7) | ||
| >=70 | 9 (0.6) | 4 (0.4) | 5 (0.7) | ||
| Residence | |||||
| Urban | 1,287 (82.1) | 727 (80.3) | 560 (84.5) | 0.08 (0.001) | 0.04 |
| Rural | 281 (17.9) | 178 (19.7) | 103 (15.5) | ||
| Education | |||||
| Elementary | 4 (0.3) | 2 (0.2) | 2 (0.3) | –0.04 (0.21) | 0.63 |
| Preparatory | 22 (1.4) | 16 (1.8) | 6 (0.9) | ||
| High school | 183 (11.7) | 107 (11.8) | 76 (11.5) | ||
| Diploma/Bachelor degree | 962 (61.4) | 557 (61.5) | 405 (61.1) | ||
| High diploma/Master/PhD | 397 (25.3) | 223 (24.6) | 174 (26.2) | ||
| Monthly income | |||||
| <500 USD | 189 (13.3) | 108 (12.9) | 81 (13.9) | −0.08 (0.002) | 0.07 |
| 500–1,000 USD | 428 (30.2) | 265 (31.8) | 163 (27.9) | ||
| 1,000–1,500 USD | 319 (22.5) | 200 (24.0) | 119 (20.4) | ||
| 1,500–2,000 USD | 188 (13.3) | 99 (11.9) | 89 (15.2) | ||
| >2,000 USD | 294 (20.7) | 162 (19.4) | 132 (22.6) | ||
| Ever diagnosed with COVID-19 | |||||
| Yes | 99 (6.3) | 59 (6.5) | 40 (6.0) | –0.02 (0.35) | 0.79 |
| No | 1,289 (82.0) | 748 (82.3) | 541 (81.7) | ||
| Not sure | 183 (11.6) | 102 (11.2) | 81 (12.2) | ||
| Contact with a COVID-19 case | |||||
| Yes | 262 (16.7) | 161 (17.7) | 101 (15.2) | –0.03 (0.21) | 0.25 |
| No | 1,153 (73.4) | 664 (73.1) | 489 (73.8) | ||
| Not sure | 156 (9.9) | 83 (9.1) | 73 (11.0) | ||
| Suspected of having COVID-19 | |||||
| Yes | 779 (49.6) | 460 (50.7) | 319 (48.0) | −0.02 (0.39) | 0.59 |
| No | 661 (42.0) | 373 (41.1) | 288 (43.4) | ||
| Not sure | 132 (8.4) | 75 (8.3) | 57 (8.6) | ||
| History of chronic disease(s) | |||||
| Yes | 309 (19.7) | 182 (20.0) | 127 (19.0) | 0.004 (0.87) | 0.25 |
| No | 1,276 (80.3) | 727(80.0) | 540 (81.0) | ||
| Heard about clinical trial s before | |||||
| Yes | 1,174 (74.9) | 680 (75.1) | 494 (74.5) | 0.002 (0.98) | 0.78 |
| No | 402 (25.1) | 229 (24.9) | 173 (25.5) | ||
*
This P-value is based on Chi-square test.
**
Bold values indicate significant P values (<0.05).